Protalix BioTherapeutics (PLX) Prepaid Assets (2014 - 2026)
Protalix BioTherapeutics (PLX) posted quarterly Prepaid Assets of $1.1 million for Q1 2026, down 27.74% year-over-year from $1.6 million in Q1 2025, and up 1.77% quarter-over-quarter from $1.1 million in Q4 2025.
Protalix BioTherapeutics (PLX) Prepaid Assets (2014 - 2026) Analysis & Trends
Protalix BioTherapeutics' Prepaid Assets history runs 13 years deep, the most recent figure standing at $1.1 million for Q1 2026.
- In Q1 2026, Prepaid Assets fell 27.74% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $1.1 million (down 27.74% YoY), while the FY2025 annual figure was $1.1 million, up 125.8% from the prior year.
- Prepaid Assets for Q1 2026 stood at $1.1 million, up from $1.1 million in the prior quarter.
- The five-year high for Prepaid Assets was $2.6 million in Q2 2022, with the low at $500000.0 in Q4 2024.
- The 5-year median for Prepaid Assets is $1.1 million (2025), against an average of $1.3 million.
- The sharpest annual moves came in 2024 and 2025: Prepaid Assets tumbled 52.61% in 2024, then surged 125.8% in 2025.
- Protalix BioTherapeutics' Prepaid Assets stood at $774000.0 in 2022, then surged by 36.3% to $1.1 million in 2023, then sank by 52.61% to $500000.0 in 2024, then soared by 125.8% to $1.1 million in 2025, then advanced by 1.77% to $1.1 million in 2026.
- Business Quant data shows PLX's Prepaid Assets at $1.1 million in Q1 2026, $1.1 million in Q4 2025, and $1.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Protalix BioTherapeutics | 189.97 Mn | 149.31 Mn | 12.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.05 Mn |
| Mar 31, 2026 | 1.15 Mn |
| Dec 31, 2025 | 1.13 Mn |
| Sep 30, 2025 | 1.45 Mn |
| Jun 30, 2025 | 1.51 Mn |
| Mar 31, 2025 | 1.59 Mn |
| Dec 31, 2024 | 500,000.00 |
| Sep 30, 2024 | 1.05 Mn |
| Jun 30, 2024 | 1.49 Mn |
| Mar 31, 2024 | 812,000.00 |
| Dec 31, 2023 | 1.06 Mn |
| Sep 30, 2023 | 1.13 Mn |
| Jun 30, 2023 | 1.71 Mn |
| Mar 31, 2023 | 758,000.00 |
| Dec 31, 2022 | 774,000.00 |
| Sep 30, 2022 | 1.74 Mn |
| Jun 30, 2022 | 2.60 Mn |
| Mar 31, 2022 | 1.12 Mn |
| Dec 31, 2021 | 1.29 Mn |
| Sep 30, 2021 | 2.27 Mn |